Form 4: Avid Bioservices CFO Acquires Shares Through Employee Stock Purchase Plan

Sentiment:

SEC Form 4


Avid Bioservices' Chief Financial Officer, Daniel R. Hart, acquired 1,755 shares of common stock through the company's Employee Stock Purchase Plan at a price of $6.052 per share.

Summary

  • Daniel R. Hart, the Chief Financial Officer of Avid Bioservices, Inc., acquired 1,755 shares of the company's common stock on December 31, 2024.
  • The shares were purchased through the company's Employee Stock Purchase Plan (ESPP).
  • The purchase price was $6.052 per share.
  • The ESPP offering period was from July 1, 2024, through December 31, 2024.
  • The purchase price was set at 85% of the closing price of Avid Bioservices' common stock on July 1, 2024.
  • Following the transaction, Mr. Hart directly owns 112,735 shares of Avid Bioservices common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, indicating a positive alignment of management and shareholder interests through the ESPP. It is not a major event but is a positive sign.

Positives

  • The purchase of shares by the CFO demonstrates confidence in the company's future.
  • The ESPP allows employees to acquire shares at a discounted price, aligning their interests with shareholders.

Industry Context

This is a routine transaction related to employee compensation and is common in publicly traded companies. It does not indicate any specific trend in the CDMO industry.

Comparison to Industry Standards

  • Employee stock purchase plans are a common practice among publicly traded companies, including those in the biotechnology and CDMO sectors.
  • The discount of 15% from the market price on the offering date is a typical discount offered in ESPPs.
  • Similar transactions are regularly reported by executives at companies like Catalent and Lonza, which are also major players in the CDMO space.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it aligns management's interests with the company's performance.
  • Employees benefit from the discounted share purchase through the ESPP.

Key Dates

DateDescription
07/01/2024Start of the ESPP offering period and date used to calculate the purchase price.
12/31/2024Date of the share purchase transaction.
01/02/2025Date the Form 4 was signed.

Keywords

Avid Bioservices, CDMO, Employee Stock Purchase Plan, ESPP, insider trading, Daniel R. Hart, Chief Financial Officer, share acquisition, common stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.